J. Epstein

1.4k total citations
41 papers, 1.1k citations indexed

About

J. Epstein is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J. Epstein has authored 41 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J. Epstein's work include Cystic Fibrosis Research Advances (9 papers), DNA Repair Mechanisms (5 papers) and Nuclear Structure and Function (5 papers). J. Epstein is often cited by papers focused on Cystic Fibrosis Research Advances (9 papers), DNA Repair Mechanisms (5 papers) and Nuclear Structure and Function (5 papers). J. Epstein collaborates with scholars based in United States and Israel. J. Epstein's co-authors include John B. Little, Jerry R. Williams, Ralph R. Weichselbaum, Peter Hudson, David T. MacLaughlin, Jan L. Breslow, R. Blake Pepinsky, Irene Dougas, Richard L. Cate and Paul L. Kornblith and has published in prestigious journals such as Science, New England Journal of Medicine and Cell.

In The Last Decade

J. Epstein

40 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Epstein United States	18	520	202	199	195	178	41	1.1k
Claire Y. Fung United States	19	425 0.8×	147 0.7×	375 1.9×	77 0.4×	118 0.7×	32	2.2k
Norimichi Nemoto Japan	21	613 1.2×	192 1.0×	430 2.2×	66 0.3×	211 1.2×	105	1.7k
Laura Woods United States	11	397 0.8×	186 0.9×	42 0.2×	166 0.9×	100 0.6×	16	1.1k
Shai Yarkoni Israel	21	346 0.7×	90 0.4×	113 0.6×	67 0.3×	254 1.4×	63	1.4k
H. Behrendt Netherlands	24	325 0.6×	72 0.4×	129 0.6×	746 3.8×	93 0.5×	74	1.5k
Brendan F. Murphy Australia	17	321 0.6×	73 0.4×	84 0.4×	91 0.5×	35 0.2×	32	1.3k
P Malet France	15	336 0.6×	76 0.4×	92 0.5×	142 0.7×	214 1.2×	65	768
Sudershan K. Bhatia United States	20	333 0.6×	47 0.2×	240 1.2×	70 0.4×	108 0.6×	42	1.6k
Phil Hass United States	9	424 0.8×	134 0.7×	31 0.2×	62 0.3×	58 0.3×	11	1.0k
Michael V. Viola United States	18	626 1.2×	34 0.2×	184 0.9×	66 0.3×	158 0.9×	34	1.4k

Countries citing papers authored by J. Epstein

Since Specialization

Citations

This map shows the geographic impact of J. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Epstein more than expected).

Fields of papers citing papers by J. Epstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Epstein. The network helps show where J. Epstein may publish in the future.

Co-authorship network of co-authors of J. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of J. Epstein. A scholar is included among the top collaborators of J. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Epstein. J. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

MacLaughlin, David T., J. Epstein, & Patricia K. Donahoe. (1991). Bioassay, purification, cloning, and expression of Müllerian inhibiting substance. Methods in enzymology on CD-ROM/Methods in enzymology. 198. 358–369. 17 indexed citations

Catlin, Elizabeth A., Susan M. Powell, T F Manganaro, et al.. (1990). Sex-specific Fetal Lung Development and Müllerian Inhibiting Substance. American Review of Respiratory Disease. 141(2). 466–470. 52 indexed citations

Hudson, Peter, Irene Dougas, Richard L. Cate, et al.. (1990). An Immunoassay to Detect Human Mullerian Inhibiting Substance in Males and Females during Normal Development*. The Journal of Clinical Endocrinology & Metabolism. 70(1). 16–22. 209 indexed citations

Epstein, J., et al.. (1989). Stainless steel mesh supports high density cell growth and production of recombinant Mullerian Inhibiting Substances. In Vitro Cellular & Developmental Biology - Plant. 25(2). 213–216. 7 indexed citations

Donahoe, Patricia K., et al.. (1987). Müllerian Inhibiting Substance: Gene Structure and Mechanism of Action of a Fetal Regressor. Elsevier eBooks. 43. 431–467. 46 indexed citations

Dryja, Thaddeus P., Joyce M. Rapaport, J. Epstein, et al.. (1986). Chromosome 13 homozygosity in osteosarcoma without retinoblastoma.. PubMed. 38(1). 59–66. 82 indexed citations

Albert, D. M., et al.. (1984). Establishment of cell lines of uveal melanoma. Methodology and characteristics.. PubMed. 25(11). 1284–99. 50 indexed citations

Epstein, B., J. Epstein, & Kimie Fukuyama. (1983). Autoradiographic study of colchicine inhibition of DNA synthesis and cell migration in hairless mouse epidermis in vivo.. PubMed. 16(4). 313–9. 10 indexed citations

Epstein, J.. (1982). SV₄₀‐transformed human cells fail to grow in zinc concentrations which permit normal human fibroblast proliferation. Journal of Cellular Physiology. 110(1). 17–22. 6 indexed citations

10.

Epstein, J. & Jan L. Breslow. (1981). Human osteogenic sarcoma cells exhibit enhanced protein phosphorylation. Biochimica et Biophysica Acta (BBA) - General Subjects. 676(1). 68–76. 3 indexed citations

11.

Breslow, Jan L., et al.. (1981). Distinguishing Homozygous and Heterozygous Cystic Fibrosis Fibroblasts from Normal Cells by Differences in Sodium Transport. New England Journal of Medicine. 304(1). 1–5. 23 indexed citations

12.

Breslow, Jan L., et al.. (1978). Dexamethasone-resistant cystic fibrosis fibroblasts show cross-resistance to sex steroids. Cell. 13(4). 663–669. 18 indexed citations

13.

Epstein, J., Jan L. Breslow, & Robert L. Davidson. (1977). Increased dexamethasone resistance of cystic fibrosis fibroblasts.. Proceedings of the National Academy of Sciences. 74(12). 5642–5646. 13 indexed citations

14.

Breslow, Jan L., J. Epstein, & Park S. Gerald. (1977). DECREASED OUABAIN BINDING IN CYSTIC FIBROSIS FIBROBLASTS. Pediatric Research. 11(4). 453–453.

15.

Breslow, J L, et al.. (1977). Decreased ouabain binding in cystic fibrosis fibroblasts in potassium-free medium. Experimental Cell Research. 110(2). 399–407. 7 indexed citations

16.

Epstein, J., A. Leyva, William N. Kelley, & John W. Littlefield. (1977). Mutagen-induced diploid human lymphoblast variants containing altered hypoxanthine guanine phosphoribosyl transferase. Somatic Cell and Molecular Genetics. 3(2). 135–148. 16 indexed citations

17.

Weichselbaum, Ralph R., J. Epstein, John B. Little, & Paul L. Kornblith. (1976). In vitro cellular radiosensitivity of human malignant tumors. European Journal of Cancer (1965). 12(1). 47–51. 49 indexed citations

18.

Little, John B., J. Epstein, & Jerry R. Williams. (1975). Repair of DNA Strand Breaks in Progeric Fibroblasts and Aging Human Diploid Cells. PubMed. 5B. 793–800. 7 indexed citations

19.

Epstein, J. & G. O. Schenc̀k. (1974). DNA synthesis and cell proliferation in the epidermis following UV- irradiation. OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information). 3 indexed citations

20.

Rozenszajn, L. A., et al.. (1968). The Esterase Activity in Megaloblasts, Leukaemic and Normal Haemopoietic Cells. British Journal of Haematology. 14(6). 605–610. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact